Update : Jul. 08, 2011
[Tokyo Stock Exchange, Inc.]
TSE has decided on delisting and designation as Securities to Be Delisted as follows.
|(1) Issue Name||
LTT Bio-Pharma Co., Ltd. stock
(Code: 4566, Market Division: Mothers)
|(2)Period of Designation as Securities to Be Delisted||From Jul. 8, 2011 (Fri.) to Aug. 8, 2011 (Mon.)|
Aug. 9, 2011 (Tue.)
(Note) In cases where circumstances in which the company should be promptly delisted occur, TSE may change the period of designation as Securities to Be Delisted and the delisting date.
|(4) Provision||Securities Listing Regulations, Rule 601, Paragraph 1, Item 9, Sub-item a (according to Securities Listing Regulations, Rule 603, Paragraph 1, Item 6) (Due to falling under inappropriate merger, etc.)|
LTT Bio-Pharma Co., Ltd. (hereinafter "the Company") acquired 100% of share ownership of Asclepius Co., Ltd. (Unlisted) via stock transfer on Sep. 1, 2007 (Sat.). Due to such stock transfer, during the period until Mar. 31, 2011 (Thu.), the Company's stock entered into a grace period pertaining to loss of substantial survival due to merger, etc.
If the Company did not file application pertaining to examination in accordance with the initial listing examination criteria by the 8th day (excluding holidays) following the date of submission (Jun. 28, 2011 (Tue.)) of the first securities report after the grace period ended, it would be delisted, and application was not filed by the application deadline of Jul. 7, 2011 (Thu.).
Stocks of the same company will be excluded from securities in lieu of money for the following items from Jul. 11, 2011 (Mon.) inclusive.
- Customer margin for margin trading and when-issued transactions
- Trading margin for when-issued transactions
- Trading participant security money
- Participant bond
DISCLAIMER: This translation may be used only for reference purposes. This English version is not an official translation of the original Japanese document. In cases where any differences occur between the English version and the original Japanese version, the Japanese version shall prevail. Tokyo Stock Exchange, Inc., Tokyo Stock Exchange Group, Inc., and/or Tokyo Stock Exchange Regulation shall individually or jointly accept no responsibility or liability for damage or loss caused by any error, inaccuracy, or misunderstanding with regard to this translation.
Tokyo Stock Exchange, Inc.
Listed Company Services